We confirm the results of others who similarly observed increased TGFβ signatures in the hyperoxia-injured neonatal lung and have generated interest in targeting this pathway as a therapeutic intervention for BPD. The gene discussed is TGFB1; the disease is bronchopulmonary dysplasia.